|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$3.17 - $4.39
$3.17 - $4.39
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$27.25 - $29.11
$27.3 - $29.1
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
Intercept Pharmaceuticals In
|
Q3 2021
Filed on Nov 15, 2021
|
5,044,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$14.75 - $20.05
$14.8 - $20.1
|
|
Invivo Therapeutics Hldgs CO
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
303
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$43.8 - $94.4
$43.8 - $94.4
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$7.05 - $11.23
$7.05 - $11.2
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
4
|
$0.54 - $2.29
$2.16 - $9.16
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$1.89 - $2.51
$1.89 - $2.51
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
85
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$2.82 - $4.27
$2.82 - $4.27
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$2.2 - $3.17
$2.2 - $3.17
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$6.6 - $9.0
$6.6 - $9
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
312,500
|
$2.61 - $3.84
$816K - $1.2M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
345,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$1.67 - $3.51
$1.67 - $3.51
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
3
|
$4.28 - $5.94
$12.8 - $17.8
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
988,200
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
3,233,351
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
6,861,289
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
$2.15 - $3.92
$2.15 - $3.92
|
|
Guggenheim Cr Allocation Fd
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|